Social engagement
Social engagement: 1.1K social following, 8 posts in the last 12 months — below the industry typical range.
Investor mix
6 investors on record; lead investors include CDH.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 2 | 33% |
| Private equity | 2 | 33% |
| Other / undisclosed | 2 | 33% |
Hiring activity
Hires occasionally
4 roles tracked across 1 of the last 12 months
23 Jun 2026 · Head of Oral Peptide Development, Head of Peptide-Oligonucleotide Conjugate (POC) Development, Head of Clinica · Hybrid
18 Jun 2026 · Head of Peptide-Oligonucleotide Conjugate (POC) Development · Hybrid
17 Jun 2026 · Head of Oral Peptide Development
17 Jun 2026 · Head of Peptide Oligonucleotide Conjugate (POC) Development
Based on job postings tracked across public sources.
Recent activity
15 Oct 2025
Partnership
RLT community